Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “California”

A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)Recruiting
NCT06452277Phase 3Updated Sep 10, 2026
Sponsor: Bayer
Advanced Non-small Cell Lung Cancer, HER2 Mutation
United States, Argentina, Australia, Austria, Belgium +31 more
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung CancerRecruiting
NCT06287775Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Extensive Stage Lung Small Cell Carcinoma · Stage IV Lung Cancer AJCC v8
United States
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 MutationRecruiting
NCT04858334Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Pancreatic Acinar Cell Carcinoma · Pancreatic Adenosquamous Carcinoma · Pancreatic Squamous Cell Carcinoma · Resectable Pancreatic Acinar Cell Carcinoma
United States, Israel, Puerto Rico
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBMRecruiting
NCT05902169Phase 3Updated Sep 10, 2026
Sponsor: CarThera
Glioblastoma · Recurrent Glioblastoma · GBM
United States, Austria, Belgium, Denmark, France +6 more
Peri-operative Oral Pain Control Following Buccal Graft UrethroplastyCompleted
NCT05300685Phase 3Updated Sep 10, 2026
Sponsor: University of California, San Francisco
Urethral Stricture, Male
United States
Vilastobart (XTX101) Monotherapy and Vilastobart and Atezolizumab Combination Therapy in Advanced Solid TumorsCompleted
NCT04896697Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: Xilio Development, Inc.
Advanced Solid Tumor
United States
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated GlioblastomaRecruiting
NCT07452458Phase 3Updated Sep 10, 2026
Sponsor: NRG Oncology
Glioblastoma, IDH-Wildtype · MGMT-Unmethylated Glioblastoma
United States
Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia (TouCAHn)Completed
NCT05907291Phase 2Updated Sep 10, 2026
Sponsor: Crinetics Pharmaceuticals Inc.
Congenital Adrenal Hyperplasia · Classic Congenital Adrenal Hyperplasia
United States, Argentina, Brazil, Germany, India +2 more
Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) MutationActive Not Recruiting
NCT03953898Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Acute Myeloid Leukemia · Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome · Acute Myeloid Leukemia Post Cytotoxic Therapy · Recurrent Acute Myeloid Leukemia
United States
Teaching Obesity Treatment Options to Adult Learners (TOTAL): A Multisite RCTCompleted
NCT05346575NAUpdated Sep 10, 2026
Sponsor: VA Office of Research and Development
Obesity · Overweight
United States
Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant SchizophreniaRecruiting
NCT07184619Phase 3Updated Sep 10, 2026
Sponsor: Newron Pharmaceuticals SPA
Treatment-resistant Schizophrenia
United States, Argentina, India, Malaysia
Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care GiversRecruiting
NCT06524973NAUpdated Sep 10, 2026
Sponsor: City of Hope Medical Center
Metastatic Pancreatic Adenocarcinoma
United States
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic LeukemiaRecruiting
NCT07061951Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Recurrent Chronic Lymphocytic Leukemia · Recurrent Small Lymphocytic Lymphoma · Refractory Chronic Lymphocytic Leukemia · Refractory Small Lymphocytic Lymphoma
United States
BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.Recruiting
NCT07605429Phase 3Updated Sep 10, 2026
Sponsor: OHB Pediatrics Ltd.
Angelman Syndrome
United States
Abbott Cephea Mitral Valve Disease RegistryRecruiting
NCT07069673N/AUpdated Sep 10, 2026
Sponsor: Abbott Medical Devices
Mitral Regurgitation · Mitral Stenosis · Mitral Valve Disease · Mitral Valve (MV) Regurgitation
United States
An Ethnobridging TriaL of AGA2118 in Healthy Japanese, Chinese, and Caucasian ParticipantS (ATLAS)Completed
NCT07361354Phase 1Updated Sep 10, 2026
Sponsor: Angitia Incorporated Limited
Healthy Participants · Pharmacokinetic Study
United States
Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine CancerActive Not Recruiting
NCT04394858Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Advanced Adrenal Gland Pheochromocytoma · Advanced Paraganglioma · Metastatic Adrenal Gland Pheochromocytoma · Metastatic Paraganglioma
United States
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)Recruiting
NCT06064097Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Stage II Nasopharyngeal Carcinoma AJCC v8 · Stage III Nasopharyngeal Carcinoma AJCC v8 · Stage IV Nasopharyngeal Carcinoma AJCC v8
United States, Australia, Canada, New Zealand, Puerto Rico
Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer.Terminated
NCT05111626Phase 3Updated Sep 10, 2026
Sponsor: Amgen
Gastric Cancer · Gastroesophageal Junction Adenocarcinoma
United States, Argentina, Australia, Austria, Belgium +24 more
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung CancerRecruiting
NCT07659782Phase 2Updated Sep 10, 2026
Sponsor: Verastem, Inc.
Non-Small Cell Lung Cancer
United States, Australia
Solutions for Hunger And Regulating EatingCompleted
NCT05004883NAUpdated Sep 10, 2026
Sponsor: University of California, San Diego
Overweight and Obesity
United States
Compassionate Use of Concizumab if You Have HaemophiliaAvailable
NCT04921956N/AUpdated Sep 10, 2026
Sponsor: Novo Nordisk A/S
Congenital Haemophilia
United States, Bulgaria, Sweden
Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up CareRecruiting
NCT05641961NAUpdated Sep 10, 2026
Sponsor: University of California, San Francisco
Childhood Cancer · Hematopoietic and Lymphoid Cell Neoplasm · Malignant Solid Neoplasm
United States
Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung CancerActive Not Recruiting
NCT04310007Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Metastatic Lung Non-Squamous Non-Small Cell Carcinoma · Recurrent Lung Non-Squamous Non-Small Cell Carcinoma · Stage IV Lung Cancer AJCC v8
United States
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPDRecruiting
NCT07610395Phase 2Updated Sep 10, 2026
Sponsor: Altesa Biosciences, Inc.
Rhinovirus Infection
United States, United Kingdom

Previous page Next page